Literature DB >> 24927273

Highly parallel characterization of IgG Fc binding interactions.

Austin W Boesch1, Eric P Brown1, Hao D Cheng2, Maame Ofua Ofori1, Erica Normandin1, Peter A Nigrovic3, Galit Alter4, Margaret E Ackerman5.   

Abstract

Because the variable ability of the antibody constant (Fc) domain to recruit innate immune effector cells and complement is a major factor in antibody activity in vivo, convenient means of assessing these binding interactions is of high relevance to the development of enhanced antibody therapeutics, and to understanding the protective or pathogenic antibody response to infection, vaccination, and self. Here, we describe a highly parallel microsphere assay to rapidly assess the ability of antibodies to bind to a suite of antibody receptors. Fc and glycan binding proteins such as FcγR and lectins were conjugated to coded microspheres and the ability of antibodies to interact with these receptors was quantified. We demonstrate qualitative and quantitative assessment of binding preferences and affinities across IgG subclasses, Fc domain point mutants, and antibodies with variant glycosylation. This method can serve as a rapid proxy for biophysical methods that require substantial sample quantities, high-end instrumentation, and serial analysis across multiple binding interactions, thereby offering a useful means to characterize monoclonal antibodies, clinical antibody samples, and antibody mimics, or alternatively, to investigate the binding preferences of candidate Fc receptors.

Entities:  

Keywords:  Fc domain; Fcγ receptor; IgG; antibody; glycosylation; lectin; luminex; multiplex

Mesh:

Substances:

Year:  2014        PMID: 24927273      PMCID: PMC4171026          DOI: 10.4161/mabs.28808

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  56 in total

1.  Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1.

Authors:  Thomas C Nesspor; T Shantha Raju; Chen-Ni Chin; Omid Vafa; Randall J Brezski
Journal:  J Mol Recognit       Date:  2012-03       Impact factor: 2.137

Review 2.  Isotype and glycoform selection for antibody therapeutics.

Authors:  Roy Jefferis
Journal:  Arch Biochem Biophys       Date:  2012-03-23       Impact factor: 4.013

3.  Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells.

Authors:  X Dong; W J Storkus; R D Salter
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 4.  Translating basic mechanisms of IgG effector activity into next generation cancer therapies.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Cancer Immun       Date:  2012-05-01

5.  Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor.

Authors:  Yang Feng; Rui Gong; Dimiter S Dimitrov
Journal:  Protein Expr Purif       Date:  2011-03-29       Impact factor: 1.650

6.  Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment.

Authors:  Max Warncke; Thomas Calzascia; Michele Coulot; Nicole Balke; Ratiba Touil; Frank Kolbinger; Christoph Heusser
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

7.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

8.  Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation.

Authors:  Fabian Käsermann; David J Boerema; Monika Rüegsegger; Andreas Hofmann; Sandra Wymann; Adrian W Zuercher; Sylvia Miescher
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

Review 9.  Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function.

Authors:  Hongcheng Liu; Kimberly May
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

10.  Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions.

Authors:  Kavitha Baruah; Thomas A Bowden; Benjamin A Krishna; Raymond A Dwek; Max Crispin; Christopher N Scanlan
Journal:  J Mol Biol       Date:  2012-04-05       Impact factor: 5.469

View more
  40 in total

1.  Antibody humanization by structure-based computational protein design.

Authors:  Yoonjoo Choi; Casey Hua; Charles L Sentman; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

2.  Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Authors:  Austin W Boesch; James H Kappel; Alison E Mahan; Thach H Chu; Andrew R Crowley; Nana Y Osei-Owusu; Galit Alter; Margaret E Ackerman
Journal:  Biotechnol Bioeng       Date:  2018-02-01       Impact factor: 4.530

3.  HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.

Authors:  Rebecca T Veenhuis; Zachary T Freeman; Jack Korleski; Laura K Cohen; Guido Massaccesi; Alessandra Tomasi; Austin W Boesch; Margaret E Ackerman; Joseph B Margolick; Joel N Blankson; Michael A Chattergoon; Andrea L Cox
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

4.  Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Authors:  Monica Vaccari; Shari N Gordon; Slim Fourati; Luca Schifanella; Namal P M Liyanage; Mark Cameron; Brandon F Keele; Xiaoying Shen; Georgia D Tomaras; Erik Billings; Mangala Rao; Amy W Chung; Karen G Dowell; Chris Bailey-Kellogg; Eric P Brown; Margaret E Ackerman; Diego A Vargas-Inchaustegui; Stephen Whitney; Melvin N Doster; Nicolo Binello; Poonam Pegu; David C Montefiori; Kathryn Foulds; David S Quinn; Mitzi Donaldson; Frank Liang; Karin Loré; Mario Roederer; Richard A Koup; Adrian McDermott; Zhong-Min Ma; Christopher J Miller; Tran B Phan; Donald N Forthal; Matthew Blackburn; Francesca Caccuri; Massimiliano Bissa; Guido Ferrari; Vaniambadi Kalyanaraman; Maria G Ferrari; DeVon Thompson; Marjorie Robert-Guroff; Silvia Ratto-Kim; Jerome H Kim; Nelson L Michael; Sanjay Phogat; Susan W Barnett; Jim Tartaglia; David Venzon; Donald M Stablein; Galit Alter; Rafick-Pierre Sekaly; Genoveffa Franchini
Journal:  Nat Med       Date:  2016-05-30       Impact factor: 53.440

5.  Fc Glycan-Mediated Regulation of Placental Antibody Transfer.

Authors:  Madeleine F Jennewein; Ilona Goldfarb; Sepideh Dolatshahi; Cormac Cosgrove; Francesca J Noelette; Marina Krykbaeva; Jishnu Das; Aniruddh Sarkar; Matthew J Gorman; Stephanie Fischinger; Carolyn M Boudreau; Joelle Brown; Jennifer H Cooperrider; Jasneet Aneja; Todd J Suscovich; Barney S Graham; Georg M Lauer; Tessa Goetghebuer; Arnaud Marchant; Douglas Lauffenburger; Arthur Y Kim; Laura E Riley; Galit Alter
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

6.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Authors:  David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

Review 7.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

8.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

Authors:  Dan H Barouch; Galit Alter; Thomas Broge; Caitlyn Linde; Margaret E Ackerman; Eric P Brown; Erica N Borducchi; Kaitlin M Smith; Joseph P Nkolola; Jinyan Liu; Jennifer Shields; Lily Parenteau; James B Whitney; Peter Abbink; David M Ng'ang'a; Michael S Seaman; Christy L Lavine; James R Perry; Wenjun Li; Arnaud D Colantonio; Mark G Lewis; Bing Chen; Holger Wenschuh; Ulf Reimer; Michael Piatak; Jeffrey D Lifson; Scott A Handley; Herbert W Virgin; Marguerite Koutsoukos; Clarisse Lorin; Gerald Voss; Mo Weijtens; Maria G Pau; Hanneke Schuitemaker
Journal:  Science       Date:  2015-07-02       Impact factor: 47.728

9.  Microscale purification of antigen-specific antibodies.

Authors:  Eric P Brown; Erica Normandin; Nana Yaw Osei-Owusu; Alison E Mahan; Ying N Chan; Jennifer I Lai; Monica Vaccari; Mangala Rao; Genoveffa Franchini; Galit Alter; Margaret E Ackerman
Journal:  J Immunol Methods       Date:  2015-06-12       Impact factor: 2.303

10.  IgG Binding Characteristics of Rhesus Macaque FcγR.

Authors:  Ying N Chan; Austin W Boesch; Nana Y Osei-Owusu; Ali Emileh; Andrew R Crowley; Sarah L Cocklin; Samantha L Finstad; Caitlyn H Linde; Rebecca A Howell; Isaac Zentner; Simon Cocklin; Adam R Miles; Joshua W Eckman; Galit Alter; Joern E Schmitz; Margaret E Ackerman
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.